Abstract
Hypoglycaemia is a frequent finding during the neonatal period and may be due to insulin overproduction. Patients with Beckwith-Wiedemann syndrome have reduced numbers of somatostatin-producing cells and decreased extractable somatostatin. In this study the effect of long-acting somatostatin (SMS 201–995) on the glucose and insulin levels in an infant with Beckwith-Wiedemann syndrome and hyperinsulinaemic non-ketotic hypoglycaemia is described. SMS 201–995 lowered basal insulin levels while maintaining normal glucose and insulin homeostasis. During fasting however, both glucose levels declined rapidly whereas insulin levels did not. The absence of both ketosis and elevated levels of free fatty acids and lactate during hypoglycaemia, as observed in our patient, are important diagnostic clues since the insulin levels themselves may sometimes be only slightly elevated
Similar content being viewed by others
Abbreviations
- SMS 201–995:
-
long-acting somatostatin
References
Aynsley-Green A (1981) Nesidioblastosis of the pancreas. In: Randle PJ, Steiner DF, Whelan WJ (eds) Carbohydrate metabolism and its disorders. Academic Press, London, pp 181–204
Aynsley-Green A (1989) In: Brook CGD (ed) Clinical paediatic endocrinology, 2nd ed 1, Blackwell Scientific Publications, Oxford, pp 627–628
Bauer W, Brimer V, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Aynsley-Green 31:1133–1141
Beckwith JB (1969) Birth defects. Original Article Series 1969, Vol V, 2:188
Besser GM, Mortimer CH, Carr D (1974) Growth hormone release inhibiting hormone in acromegaly. Br Med J 1:352–355
Bruining GJ, Bosschaart AN, Aarsen RSR, Lamberts SWJ, Sauer PJJ, Del Pozo E (1986) Normalization of glucose homeostasis by a long-acting somatostatin analog SMS 201–995 in a newborn with nesidioblastosis. Acta Endocrinol (Copenh) 113 [Suppl] 279:334–339
Cornblath M, Schwartz R (1976) Disorders of carbohydrate metabolism in infancy. WB Saunders, Philadelphia
Delemarre-Van De Waal HA, Veldkamp EJM, Schrander-Stumpel CTRM (1987) Long term treatment of an infant with nesidioblastosis using a somatostatin analogue. N Engl J Med 316:222–223
Del Pozo E, Neufeld M, Schlüter K, Tortosa F, Clarenbach P, Bieder E, Wendel L, Nüesch E, Marbach P, Cramer H, Kerp L (1986) Endocrine profile of a long-acting somatostatin derivate SMS 201–995. Study in normal volunteers following subcutaneous administration. Acta Endocrinol 111:433–439
Del Pozo E, Schluter K, Neufeld M, Tortosa F, Clarenbach P, Bieder E, Wendel L, Nüesch E, Marbach P, Cramer H, Kerp L (1986) Endocrine profile and pharmacokinetics of the new Somatostatin analogue SMS 201–995. Acta Endocrinol 111: 433–439
Heitz PU, Klöppel G, Häcki WH, Polak JM, Pearse AG (1977) Nesidioblastosis: the pathological basis of persistent hyperinsulinemic hypoglycemia in infants. Diabetes 26:632–642
Hindmarsh PC, Brook CGD (1987) Short term management of an infant with nesidioblastosis using somatostatin analogue SMS 201–995. N Engl J Med 316:221–222
Kirk JMW, Di Silvio L, Hindmarsh PC, Brook CGD (1988) Somatostatin analogue in short term management of hyperinsulinism. Arch Dis Child 63:1493–1494
Moncrieff MW, Lacey KA, Malleson PN (1977) Management of prolonged hypoglycaemia in Beckwith's syndrome. Postgrad Med J 53:159
Shiff D, Colle E, Wells D (1973) Metabolic aspects of the Beckwith-Wiedemann syndrome. J Pediatr 82:258–262
Verschoor L, Uitterlinder P, Lamberts SWJ, Pozo E de (1986) On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma. Clin Endocrinol 25:555–560
Willems PJ, Dijkstra I, Schierbeek HH, Berger R, Smit GPA (1988) Activation of fatty acid oxidation in the Silver-Russell syndrome and the Brachmann-de Lange Syndrome. Am J Med Genetics 30:865–873
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gerver, W.J.M., Menheere, P.P.C.A., Schaap, C. et al. The effects of a somatostatin analogue on the metabolism of an infant with Beckwith-Wiedemann syndrome and hyperinsulinaemic hypoglycaemia. Eur J Pediatr 150, 634–637 (1991). https://doi.org/10.1007/BF02072623
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02072623